N

NervGen Pharma Corp.
D

NGEN

1.59500
USD
-0.02
(-0.93%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
20,911
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
171,498,600
نظرة عامة

العنوان: NervGen Pharma Corp.

القطاع: الرعاية الصحية
الصناعة: Biotechnology
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is thediscovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.